Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 06, 2023 |
returned to assembly passed senate 3rd reading cal.75 substituted for s599a |
Jun 06, 2023 |
substituted by a1707a |
Jun 01, 2023 |
amended on third reading 599a |
Jun 01, 2023 |
vote reconsidered - restored to third reading |
May 31, 2023 |
returned to senate recalled from assembly |
May 30, 2023 |
recommitted to health substitution reconsidered |
May 15, 2023 |
ordered to third reading cal.196 substituted for a1707 |
Jan 17, 2023 |
referred to health delivered to assembly passed senate ordered to third reading cal.75 reported and committed to rules |
Jan 05, 2023 |
referred to health |
Senate Bill S599
2023-2024 Legislative Session
Sponsored By
(D, WF) 18th Senate District
Current Bill Status Via A1707 - Passed Senate
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D) 15th Senate District
(D) 16th Senate District
(D, WF) 48th Senate District
2023-S599 - Details
2023-S599 - Sponsor Memo
BILL NUMBER: S599 SPONSOR: SALAZAR TITLE OF BILL: An act to amend the insurance law, in relation to requiring certain manufacturers of prescription drugs to notify the superintendant of any proposed increase of the wholesale acquisition cost of such prescription drugs PURPOSE: This bill would require manufacturers to provide at least 60 day notice Of their intent to raise wholesale prescription drug costs to the Department of Financial Services if the increase is 10% or more of the total cost of the drug. SUMMARY OF PROVISIONS: Section 1 amends the insurance law to add new section 111-a relating to notification of prescription drug price increases by manufacturers.
2023-S599 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 599 2023-2024 Regular Sessions I N S E N A T E January 5, 2023 ___________ Introduced by Sens. SALAZAR, MAY -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the insurance law, in relation to requiring certain manufacturers of prescription drugs to notify the superintendant of any proposed increase of the wholesale acquisition cost of such prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The insurance law is amended by adding a new section 111-a to read as follows: § 111-A. NOTIFICATION OF PRESCRIPTION DRUG PRICE INCREASES BY MANUFAC- TURERS. (A) THIS SECTION SHALL APPLY TO A MANUFACTURER OF A PRESCRIPTION DRUG THAT IS PURCHASED OR REIMBURSED IN THIS STATE BY ANY OF THE FOLLOW- ING: (1) AN INSURANCE COMPANY AUTHORIZED IN THIS STATE TO WRITE ACCIDENT AND HEALTH INSURANCE, A COMPANY ORGANIZED PURSUANT TO ARTICLE FORTY- THREE OF THIS CHAPTER, A MUNICIPAL COOPERATIVE HEALTH BENEFIT PLAN ESTABLISHED PURSUANT TO ARTICLE FORTY-SEVEN OF THIS CHAPTER, AN ORGAN- IZATION CERTIFIED PURSUANT TO ARTICLE FORTY-FOUR OF THE PUBLIC HEALTH LAW, AN INSTITUTION OF HIGHER EDUCATION CERTIFIED PURSUANT TO SECTION ONE THOUSAND ONE HUNDRED TWENTY-FOUR OF THIS CHAPTER, OR THE NEW YORK STATE HEALTH INSURANCE PLAN ESTABLISHED PURSUANT TO ARTICLE ELEVEN OF THE CIVIL SERVICE LAW; OR (2) A PHARMACY BENEFIT MANAGER, INCLUDING AN ENTITY THAT DIRECTLY OR THROUGH AN INTERMEDIARY, MANAGES THE PRESCRIPTION DRUG COVERAGE PROVIDED BY A HEALTH INSURER UNDER A CONTRACT OR POLICY DELIVERED OR ISSUED FOR DELIVERY IN THIS STATE OR A HEALTH PLAN SUBJECT TO SECTION THREE HUNDRED SIXTY-FOUR-J OF THE SOCIAL SERVICES LAW, INCLUDING THE PROCESSING AND PAYMENT OF CLAIMS FOR PRESCRIPTION DRUGS, THE PERFORMANCE OF DRUG UTILI- ZATION REVIEW, THE PROCESSING OF DRUG PRIOR AUTHORIZATION REQUESTS, THE ADJUDICATION OF APPEALS OR GRIEVANCES RELATED TO PRESCRIPTION DRUG EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD00641-01-3
co-Sponsors
(D) 15th Senate District
(D, WF) 31st Senate District
(D) 16th Senate District
(D, WF) 48th Senate District
2023-S599A (ACTIVE) - Details
2023-S599A (ACTIVE) - Sponsor Memo
BILL NUMBER: S599A SPONSOR: SALAZAR TITLE OF BILL: An act to amend the insurance law, in relation to requiring certain manufacturers of prescription drugs to notify the superintendant of any proposed increase of the wholesale acquisition cost of such prescription drugs PURPOSE: This bill would require manufacturers to provide at least 60 day notice Of their intent to raise wholesale prescription drug costs to the Department of Financial Services if the increase is 10% or more of the total cost of the drug. SUMMARY OF PROVISIONS: Section 1 amends the insurance law to add new section 111-a relating to notification of prescription drug price increases by manufacturers.
2023-S599A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 599--A Cal. No. 75 2023-2024 Regular Sessions I N S E N A T E January 5, 2023 ___________ Introduced by Sens. SALAZAR, ADDABBO, LIU, MAY -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- reported favorably from said committee and committed to the Commit- tee on Rules -- reported favorably from said committee, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote reconsidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the insurance law, in relation to requiring certain manufacturers of prescription drugs to notify the superintendant of any proposed increase of the wholesale acquisition cost of such prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The insurance law is amended by adding a new section 111-a to read as follows: § 111-A. NOTIFICATION OF PRESCRIPTION DRUG PRICE INCREASES BY MANUFAC- TURERS. (A) THIS SECTION SHALL APPLY TO A MANUFACTURER OF A PRESCRIPTION DRUG THAT IS PURCHASED OR REIMBURSED IN THIS STATE BY ANY OF THE FOLLOW- ING: (1) AN INSURANCE COMPANY AUTHORIZED IN THIS STATE TO WRITE ACCIDENT AND HEALTH INSURANCE, A COMPANY ORGANIZED PURSUANT TO ARTICLE FORTY- THREE OF THIS CHAPTER, A MUNICIPAL COOPERATIVE HEALTH BENEFIT PLAN ESTABLISHED PURSUANT TO ARTICLE FORTY-SEVEN OF THIS CHAPTER, AN ORGAN- IZATION CERTIFIED PURSUANT TO ARTICLE FORTY-FOUR OF THE PUBLIC HEALTH LAW, AN INSTITUTION OF HIGHER EDUCATION CERTIFIED PURSUANT TO SECTION ONE THOUSAND ONE HUNDRED TWENTY-FOUR OF THIS CHAPTER, OR THE NEW YORK STATE HEALTH INSURANCE PLAN ESTABLISHED PURSUANT TO ARTICLE ELEVEN OF THE CIVIL SERVICE LAW; OR (2) A PHARMACY BENEFIT MANAGER, INCLUDING AN ENTITY THAT DIRECTLY OR THROUGH AN INTERMEDIARY, MANAGES THE PRESCRIPTION DRUG COVERAGE PROVIDED BY A HEALTH INSURER UNDER A CONTRACT OR POLICY DELIVERED OR ISSUED FOR EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.